UBS to Buy Oakland's Clorox Building

UBS AG plans to buy the Clorox Building in Oakland, marking another major institutional investor entering the East Bay city's office market.

The Swiss financial services firm is under contract to buy the 521k SF building at 1221 Broadway—the city's sixth-tallest building. Owner Westcore Properties bought the building at the end of 2012 for $110M. The sales price could be around $182M, according to the San Francisco Business Times.

Clorox occupies about half of the fully leased building and has a long-term, below-market lease. In Q3, Brown & Toland medical group signed a 59,500 SF lease, while Union Bank leased 37,200 SF. [SFBT]

Continue reading this story with a free account

Log in or register
Related Topics: Clorox building , Oakland , UBS AG
Sign up for more articles like this
Subscribe to Bisnow's San Francisco Newsletters
Related Stories

Defense Tech Firms Setting Up Shop In Trump Family's Palm Beach Orbit

Google Delays Thompson Center Opening To 2028, Releases New Renderings

Why Top-Secret Facilities Are Permeating Greater D.C.'s Office Market

With Occupancy Brimming, Investors Pile Into Bay Area Apartments

DivcoWest Sells Glendale Office Building For $70M

Stanford Pursuing $100M Fund For A 2M SF Expansion

Hines And Rialto Close Office Credit Fund At $1.1B

Rig Collapse At Citadel HQ Site Sends 4 To Hospital

Northern Virginia Office Tower Sells For Double Its 2024 Price

Oxford Properties' U.S. Investment Head On Why It's Buying Office Again — And Where

Fertility Provider Opens Clinic At 1900 Lawrence Office Tower: The Denver Deal Sheet

Office Revenues Are Failing To Keep Pace With Expenses